Attached files

file filename
EX-99.1 - PRESS RELEASE - MedAvail Holdings, Inc.f8k111414ex99i_myoscorp.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): November 14, 2014

 

MYOS CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   000-53298   90-0772394

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

45 Horsehill Road, Suite 106

Cedar Knolls, New Jersey 07927

 (Address of Principal Executive Offices)

 

(973) 509-0444

(Issuer’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 2.02     Results of Operations and Financial Condition.

 

On November 14, 2014, MYOS Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2014, as well as updates on operational highlights for the Company. The press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7.01     Regulation FD Disclosure.

 

The information set forth above under Item 2.02 is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information being furnished pursuant to this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01     Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 Press release announcing financial results for the quarter ended September 30, 2014.
   

  

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 14, 2014

  

  MYOS CORPORATION
     
  By: /s/ Joseph C. DosSantos
    Name: Joseph C. DosSantos
    Title:   Chief Financial Officer